Sources | Names Used |
---|---|
CTRPv2 | sirolimus:bortezomib (250:1 mol/mol) |
PharmacoGx | sirolimus:bortezomib (250:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZNF407 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-07 |
mRNA | TEAD2 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
mRNA | ZNF786 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-07 |
mRNA | CYFIP2 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-06 |
mRNA | SPDYE3 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
mRNA | KCNN3 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-07 |
mRNA | IRF4 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
mRNA | IKZF3 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |
mRNA | HDHD2 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
mRNA | LIMD2 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0001 |